(Total Views: 314)
Posted On: 12/13/2021 8:35:48 AM
Post# of 109

$REGN News Article - Positive Phase 3 Dupixent (dupilumab) Data in Children 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis Featured in RAD 2021 Late-breaking Session https://marketwirenews.com/news-releases/posi...14271.html


My Twitter: WhyteStocks